Tao Li

29PUBLICATIONS
43CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyMolecular targetsNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 01, 2026
Integrated single-cell multi-omics characterization reveals lipid-associated macrophage-mediated immunosuppression in neoadjuvant immunotherapy of hepatocellular carcinoma.

|Jun 29, 2026
Multimodal Modeling Distinguishes Treatment Response from Overall Survival in Hepatocellular Carcinoma Receiving Combined Interventional and Targeted Immunotherapy.

|Feb 27, 2026
TRIM13 in situ engineering boosts anti-inflammatory capacity of CAR-Ms for liver fibrosis therapy.

Jinxin Gao, Zhenmei Yang, Yudong Song

|Aug 25, 2025
Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma.

Yu-Chuan Yan, Li-Juan Shao, Guang-Xiao Meng

|Aug 08, 2025
Epigenetic modulation with nanosatellite triggers tumoricidal immunity for hepatocellular carcinoma treatment.

Ying Qu, Chen Chen, Feifei Sun

|Jul 31, 2025
Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma.

Rui-Zhe Li, Guo-Qiang Pan, Chen Xiong

Pageof 5

Frequent Collaborators

9 joint publications

Zhaoru Dong

5 joint publications

Lun-Jie Yan

2 joint publications

Qi-Hang Cao

2 joint publications

Hui Liu